rs1861085

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006329.4(FBLN5):​c.380-9818A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.74 in 152,162 control chromosomes in the GnomAD database, including 42,464 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.74 ( 42464 hom., cov: 32)

Consequence

FBLN5
NM_006329.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.936

Publications

3 publications found
Variant links:
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • cutis laxa, autosomal recessive, type 1A
    Inheritance: SD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Charcot-Marie-Tooth disease, demyelinating, IIA 1H
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • demyelinating hereditary motor and sensory neuropathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • macular degeneration, age-related, 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensorimotor neuropathy with hyperelastic skin
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive cutis laxa type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBLN5NM_006329.4 linkc.380-9818A>G intron_variant Intron 4 of 10 ENST00000342058.9 NP_006320.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBLN5ENST00000342058.9 linkc.380-9818A>G intron_variant Intron 4 of 10 1 NM_006329.4 ENSP00000345008.4

Frequencies

GnomAD3 genomes
AF:
0.740
AC:
112489
AN:
152044
Hom.:
42446
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.593
Gnomad AMI
AF:
0.817
Gnomad AMR
AF:
0.837
Gnomad ASJ
AF:
0.769
Gnomad EAS
AF:
0.684
Gnomad SAS
AF:
0.725
Gnomad FIN
AF:
0.852
Gnomad MID
AF:
0.750
Gnomad NFE
AF:
0.792
Gnomad OTH
AF:
0.759
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.740
AC:
112570
AN:
152162
Hom.:
42464
Cov.:
32
AF XY:
0.743
AC XY:
55291
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.593
AC:
24594
AN:
41474
American (AMR)
AF:
0.838
AC:
12814
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.769
AC:
2670
AN:
3470
East Asian (EAS)
AF:
0.684
AC:
3536
AN:
5168
South Asian (SAS)
AF:
0.725
AC:
3495
AN:
4818
European-Finnish (FIN)
AF:
0.852
AC:
9033
AN:
10598
Middle Eastern (MID)
AF:
0.752
AC:
221
AN:
294
European-Non Finnish (NFE)
AF:
0.792
AC:
53863
AN:
68012
Other (OTH)
AF:
0.756
AC:
1599
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1431
2862
4292
5723
7154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
846
1692
2538
3384
4230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.776
Hom.:
173561
Bravo
AF:
0.731
Asia WGS
AF:
0.695
AC:
2419
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.0
DANN
Benign
0.67
PhyloP100
-0.94
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1861085; hg19: chr14-92371234; API